chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial unsolicited report was received from a certified medical assistant on 23 February 2015. This case is one of a cluster of "almost 10 patients" received from the same reporter (with 8 patients identified). The other patients are captured in cases 2014SA157362, 2015SA023263, 2015SA023267, 2015SA023902, 2015SA023910, 2015SA023917, 2015SA023924, 2015SA023928. A 74 year-old patient, gender unknown had received on 13 October 2014 in the morning, an intramuscular left arm injection of FLUZONE QUADRIVALENT, lot number UI205AC with expiration date of June 2015 and at an unspecified time after vaccination was diagnosed with flu and pneumonia; the patient died on 28 December 2014, approximately 3 months after vaccination. Relevant diagnostic tests were reported as "ER + flu + pneumonia". Illness at the time of vaccination was none. Concomitant medications and pre-existing conditions were reported as "NA". No further information was provided. Outcome was fatal. According to the reporter, the report was reviewed and they had no additional information to report at the time. Documents held by sender: none.
bad chemical taste on their mouth; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (bad chemical taste on their mouth) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced DYSGEUSIA (bad chemical taste on their mouth). At the time of the report, DYSGEUSIA (bad chemical taste on their mouth) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   concomitant medication reported was thyroid medicine
flushing, throat tightness, dizziness with subsequent productive cough for following 5 days
Was having intermittent chest pain several weeks prior to 6/19 I had a heart attack due to a 95% occlusion due to a blood clot. Had cardiac cath and stent put in. On 7/3 i was hospitalized and found to have 4 pulmonary embolisms. Never had a cardiac issue, no family history of cardiac issues. Have had work up by Hematology, rheumatology, cardiology, oncology. All testing has come back with no underlying or contributing diseases. Now on life long medications, currently in cardiac rehab, still have not yet fully recovered.
After giving patient the 2nd COVID injections, he stated that his head hurt as soon as the shot was given. I had the patient stay an extra 15 min with his father, at the end the of the 15 min the patient and his father felt like the headache was better and they could leave.
bad headache; had 101.4 fever; had a large spot in my arm swelling up hard; arm hardness; spot on arm; This case was reported by a other health professional via interactive digital media and described the occurrence of headache in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced headache, fever, swelling arm, induration and rash. On an unknown date, the outcome of the headache, fever, swelling arm, induration and rash were unknown.   It was unknown if the reporter considered the headache, fever, swelling arm, induration and rash to be related to Shingrix.  Additional details were provided as follows The age at vaccination not provided. The age group was not reported but was selected as an adult as per vaccine indication.  The patient received Shingrix vacccine and experienced a large spot on arm swelled up hard and swelling below it,101.4 degree F fever and bad headache      Lab Comments: On an unknown date lab test was performed
Localized redness, swelling & central area of induration, occurred within 6-8 hrs of the receipt of the injection.
Sudden hearing loss right ear. Feels like water in the ear. Condition still persists as of 1/1/23.
I felt weird and off. I ran a slight fever. Then my right arm started swelling up really bad. I took Benadryl 25mg. The doctors think it is an allergic reaction. I also have swelling in the area that's under my arm at the upper right quadrant of my chest. My arm is still swollen.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies and concomitant medications were unknown. On 25-OCT-2016 the patient was vaccinated with an expired dose of VARIVAX (dosing details were not reported) (lot # K011802, expiry date: 21-AUG-2016). There were no known adverse effects. No product quality complaint was involved. Additional information is not expected as the reporter did not wish further contact.
Information has been received from a nurse concerning a 10 year old male child who on 05-AUG-2010 was vaccinated with VARIVAX (Merck). Concomitant therapy included ZYRTEC. On 05-AUG-2010 the patient started having excessive, continued blinking and lasted for 5days, ending on 09-AUG-2010. The patient sought unspecified medical attention. Follow-up information has been received from the registered nurse indicating that the patient with no illness at the time of vaccination (sports physical routine) and allergic rhinitis and peanut allergy and allergy to walnuts, oak trees, timothy grass, june grass, cocklebur, cashew nut, maple trees, pecan trees, birch, white ash, orchard, red top, sweat vernal, alternaria, dust mite and a history of eczema and headache who on 05-AUG-2010 10:00 AM received the second dose of VARIVAX (Merck) (lot # 661554/0435Z). On "12-AUG-2010", the patient experienced blinking, thought to be tic. On 09-AUG-2010, the patient had recovered. No further information is available.
There was an opened unlabeled vial of Moderna in the fridge. There had not been any mentions on the group chat of an open Moderna vial (as when we open each vial we let everyone in the chat know) . I grabbed the open vial along with an unopened vial of Moderna and proceeded to the Covid clinic. There were 7 doses of this vaccine given to patients. As of 9/27 we were off on our counts and now realize that the vial that was used on 9/24 to those 7 patients was an expired vial. The vial had originally been opened on 9/23 by RN. These 7 patients have been located and will be contacted once recommendations from agency are reviewed.
Pediatric dose was given to adults mistakenly; Moderna COVID-19 vaccine administered to patients post temperature excursion; Poor quality vaccine administered; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR5186C) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered).    Concomitant Medication use information was not provided by reporter.  It was reported there was a temperature excursion between 26 May 2022 to 30 Sep 2022 and lot AR5186C was affected between 08 Sep 2022 to 27 Sep 2022. AR5186C was previously reported. Pediatric dose was given to adults mistakenly and were reported to CDPH, VAERS, CAIR and each patient that received the error dose, with instructions to re-vaccinate 2 months from the initial error dose. 051B22A was kept in the freezer upon receipt of shipment on 01-Aug-2022 and individual vials were put in the refrigerator on the day of use.  Treatment Medication use information was not provided by reporter.  This case contains information for the 89th of 104 patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-669791 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-669791:Master case
Pt noticed increasing pain in (L) arm after vaccination on 10/21/10, also pt describes increasing fatigue & chills then body aches. Pt states she had a temp of 102: (L) arm began to swell & become warm to touch, which then extended to (L) neck, shoulder blade, & back.
Deep aching pain@site of injection commencing @ time of injection (into left deltoid) on 10/26/00. Left arm movement restricted-unable to raise left arm to shoulder height without deep aching pain. Left deltoid seemed to improve somewhat over time, but for past six weeks symptoms increased. Left arm movement restricted by pain
Severe Insomnia. Have no slept in 3 days. I have body aches, chills, sweats, muscle pain, severe nausea at night and in the morning with occasional vomiting. Severe headaches, mainly in the right temp; body aches; Severe Insomnia. Have no slept in 3 days. I have body aches, chills, sweats, muscle pain, severe nausea at night and in the morning with occasional vomiting. Severe headaches, mainly in the right temp; sweats; Muscle pain; Severe Insomnia. Have no slept in 3 days. I have body aches, chills, sweats, muscle pain, severe nausea at night and in the morning with occasional vomiting. Severe headaches, mainly in the right temp; occasional vomiting; Severe headaches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35 year-old male patient received bnt162b2 (BNT162B2, Solution for injection), administered in arm left, administration date 29May2021 11:00 (Lot number: Ew0217) at the age of 35 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Severe anxiety" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: INSOMNIA (non-serious), CHILLS (non-serious), NAUSEA (non-serious) all with onset 02Jun2021 06:00, outcome "not recovered" and all described as "Severe Insomnia. Have no slept in 3 days. I have body aches, chills, sweats, muscle pain, severe nausea at night and in the morning with occasional vomiting. Severe headaches, mainly in the right temp"; PAIN (non-serious) with onset 02Jun2021 06:00, outcome "not recovered", described as "body aches"; HYPERHIDROSIS (non-serious) with onset 02Jun2021 06:00, outcome "not recovered", described as "sweats"; MYALGIA (non-serious) with onset 02Jun2021 06:00, outcome "not recovered", described as "Muscle pain"; VOMITING (non-serious) with onset 02Jun2021 06:00, outcome "not recovered", described as "occasional vomiting"; HEADACHE (non-serious) with onset 02Jun2021 06:00, outcome "not recovered", described as "Severe headaches". Therapeutic measures were not taken as a result of insomnia, pain, chills, hyperhidrosis, myalgia, nausea, vomiting, headache.  Additional information: Severe Insomnia. Have no slept in 3 days. I have body aches, chills, sweats, muscle pain, severe nausea at night and in the morning with occasional vomiting. Severe headaches, mainly in the right temple.  Follow-up attempts are completed. No further information is expected.
Symptoms include fever, chills, muscle aches, cough, congestion, runny nose, headaches, and fatigue and sore throat.
I started out having postnasal drip on January 31. I did take pharmacy sinus congestion PE which didn't help at all. I had a low-grade fever of about 100, lots of fatigue and a migraine. I dealt with this for one day then I took a home test and the results were bright pink stating a positive reading for COVID-19. I then contacted my doctor and was given PAXLOIVD. I'm not sure if the medication worked because all symptoms were gone by the time, I got the script. I am still dealing with the cough maybe from the long-term postnasal drip. If I had to describe this, I would say I had a mild case I just have the cough still. I have been told its common to have this cough.
Vaccine dose was less than 0.5ml; Vaccine dose as it was given to a patient squirted out from the needle; A spontaneous report was received from a physician concerning a patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and the vaccine dose was less than 0.5ml and vaccine dose as it was given to a patient squirted out from the needle.   The patient's medical history was not provided. No relevant concomitant medications were reported.   On unknown date, the patient received their first of two planned doses of mRNA-1273 (Lot number: 025J20A) intramuscularly for prophylaxis of COVID-19 infection.   On an unknown date, the vaccine was being administered to the patient, the vaccine squirted out from the needle and the patient only received the left over dose from the needle. The patient received less than 0.5 ml of the Moderna Covid-19 vaccine.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The events, vaccine dose was less than 0.5ml and vaccine dose as it was given to a patient squirted out from the needle , were considered resolved on unknown date.; Reporter's Comments: This case concerns a patient of unknow age and gender, who experienced an unexpected event of inappropriate dose administered (less than 0.5ml was given) and vaccine squirted out of needle. The event occurred on an unknown date during the administration of the first dose of mRNA-1273(Lot number: 025J20A). This report refers to a case of Product administration error and inappropriate dose administered for mRNA-1273(Lot number: 025J20A).
Information has been received from a registered nurse concerning a 33 year old healthy male with no drug reactions/allergies who on 02/10/2005 was vaccinated with a dose of varicella virus vaccine live.  There was no concomitant vaccinations.  On 02/27/2005, the patient developed 20-30 red raised skin eruptions on his chest, neck, scalp, and arms.  He also had arthralgia, a headache, and sleep difficulties.  He was treated with ibuprofen and cortisone cream.  The outcome was reported as not recovered.  Unspecified medical attention was sought.  There was no product quality complaint.  Additional information has been requested.
I had soreness in my left arm for 2 days. Muscle aches for 1 day. I had a headache on 12-24-2020. I also had chills on 12-25-2020 with muscle aches.  The muscle aches got worse on 12-26-2020 and that's when I visited an urgent care center.  At the ER they did a nasal swab test, covid test.
The pt experienced flu like symptoms, sore muscles and mild fever, mild swelling, soreness in glands under jaw. Swelling and soreness in the arm.
Information has been received from a nurse practitioner concerning a 12 year old female patient with no known drug reactions or allergies and no pertinent medical history, who on 09-SEP-2009 was vaccinated with the first dose of GARDASIL (Lot # 663452/0671Y). Concomitant therapy included MENACTRA. The nurse practitioner reported that on 10-SEP-2009 the patient developed nausea, dizziness, stomach ache, fever (100.5 degrees F) and blisters on both ears after vaccination with her first dose of GARDASIL. The reporter stated the blisters were on the top of the patient's ear, and were about 2 cm by 0.5 cm in size. The patient sought medical attention; she was seen in the office. At the time of the report the patient had not recovered. There were no lab diagnostic studies performed. Additional information has been requested.
Pt vaccinated with DTP and developed 5 X 2 cm red indurated area around injection site
Two weeks after the first dose of the Pfizer Biotech vaccination, I developed a case of acute herpes zoster that required an urgent care visit and antiviral medication.
Mild fever (<100); Body ache; tiredness; sore joints; headache; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 31Mar2021 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included sleep apnea. Patient reported allergy to shellfish. Concomitant medications included escitalopram oxalate (LEXAPRO) loteprednol etabonate (LOTREL) simvastatin (MANUFACTURER UNKNOWN) and vitamins(unspecified); all from an unknown date and for an unknown indication. The patient previously took BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 10Mar2021 at 14:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 31Mar2021 at 14:00, the patient experienced mild fever (<100), body ache, tiredness, sore joints and headache. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events mild fever, body ache, tiredness, sore joints and headache were recovered on an unknown date in 2021 at the time of this report.   No follow-up attempts are needed. No further information is expected.
YELLOW SPOT IN EYES; 2 KNOTS ON HEAD THAT ARE SORE TO TOUCH; VACCINE WITH TWITCHING; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 2021, the subject experienced vaccine with twitching. On an unspecified date, the subject experienced yellow spot in eyes, and 2 knots on head that are sore to touch. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from vaccine with twitching on 2021, and the outcome of yellow spot in eyes and 2 knots on head that are sore to touch was not reported. This report was non-serious.
Vomiting 15 hours after vaccination. Extreme fatigue, lethargy, headache, loss of appetite for 48 hours after vaccination.
CARDIAC ARREST ON 5/26/21,  ADMITTED TO ICU Care for several weeks.  June 9  IAED pacemaker inserted.  Eventually discharged with encephalopathy and EF 40%.
heart pain; Fever 100.9; (L) arm pain down to fingers and back up to shoulder and neck; (L) arm pain down to fingers and back up to shoulder and neck; (L) arm pain down to fingers and back up to shoulder and neck; Increased (L) lymph node, grape size; Muscle aches; fatigue; diarrhea; Chest palpitations; Arthritis flare; This is a spontaneous report from a non-contactable consumer (patient). A 53-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date (Lot Number: ew0183) as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported.  The patient experienced fever 100.9, left (L) arm pain down to fingers and back up to shoulder and neck. Increased (L) lymph node, grape size. Called PCP and was told to see a surgeon for removal. Muscle aches, fatigue, diarrhea, heart pain, chest palpitations, arthritis flare. The patient had not COVID and she was non COVID tested post vaccination. The outcome of events was unknown.   No follow-up attempts are possible. No further information is expected.
Patient was not feeling well after  receiving Pfizer Covid-19 Vaccine. Patient was pale and complaining dizziness and nausea. after a few minutes, these symptoms are gone.
Case number PHEH2015US027174, is an initial spontaneous report received from a medical assistant on 24 Dec 2015. This report refers to a 63 years old male patient. Past medical history and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1516201) at a dose of 0.5 ml, intramuscularly on an unknown date which was stored out of recommended temperature range (temperature excursion of 55.6 degree Fahrenheit/at 7.50 am the temperature was 38 degrees and at 3.50pm the temperature was 38.3 degrees). No adverse event reported following this medication errors.
received her first dose of the Pfizer COVID-19 vaccine  and then developed COVID-19; received her first dose of the Pfizer COVID-19 vaccine  and then developed COVID-19; This is a spontaneous report received from a Pfizer-sponsored program. The reporter is a  contactable nurse (patient)    A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 01Dec2020 (Batch/Lot number was not reported) as single dose for covid-19 immunisation  .  The patient medical history and concomitant medications were not reported.  The patient experienced received her first dose of the pfizer covid-19 vaccine and then developed covid-19 on an unspecified date with outcome of unknown.  The patient underwent lab tests and procedures which included sars-cov-2 test: positive on an  unknown date.  Course of the event. The patient received her 1st dose of Covid vaccine on December 1st. She was suppose to get her 2nd dose but developed Covid. She has not received her 2nd dose and is wondering if she can take it now or if she needs to start over with 1st dose.  Information about the Lot/batch number has been requested.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. However, full immunity is only expected 7 days after the second dose.